PubRank

D G Pfister

Author PubWeight™ 41.54‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001 3.06
2 Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology. J Clin Oncol 1999 2.97
3 Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study. J Clin Oncol 1993 2.42
4 American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel. J Clin Oncol 2000 2.39
5 American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants. J Clin Oncol 1999 2.03
6 Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol 2002 1.96
7 Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue. Head Neck 1997 1.71
8 Genetic analysis as an aid in diagnosis for patients with midline carcinomas of uncertain histologies. J Natl Cancer Inst 1991 1.55
9 American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene. J Clin Oncol 1999 1.52
10 2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines. J Clin Oncol 2000 1.43
11 Factors associated with complications in microvascular reconstruction of head and neck defects. Plast Reconstr Surg 1999 1.40
12 Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology. J Clin Oncol 1999 1.39
13 Initial clinical trial of a selective retinoid X receptor ligand, LGD1069. J Clin Oncol 1997 1.34
14 Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer. Head Neck 1997 1.08
15 Improved long-term survival with combined modality therapy for pediatric nasopharynx cancer. Int J Radiat Oncol Biol Phys 2000 1.03
16 Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma. J Clin Oncol 2001 0.97
17 The rightward shift of colon cancer. Aging or artifact? J Clin Gastroenterol 1987 0.88
18 Long term results of primary radiotherapy with/without neck dissection for squamous cell cancer of the base of tongue. Head Neck 1998 0.87
19 Concomitant chemotherapy-radiation therapy followed by hyperfractionated radiation therapy for advanced unresectable head and neck cancer. Int J Radiat Oncol Biol Phys 1991 0.84
20 Failure of a 3D conformal boost to improve radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2001 0.83
21 Long-term regional control after radiation therapy and neck dissection for base of tongue carcinoma. Int J Radiat Oncol Biol Phys 1997 0.80
22 Management of unresectable malignant tumors at the skull base using concomitant chemotherapy and radiotherapy with accelerated fractionation. Skull Base Surg 1994 0.80
23 The Collection of Indirect and Nonmedical Direct Costs (COIN) form: a new tool for collecting the invisible costs of androgen independent prostate carcinoma. Cancer 2001 0.80
24 Carboplatin, etoposide, and bleomycin for patients with poor-risk germ cell tumors. Cancer 1990 0.80
25 Diagnostic criteria and technology as sources for changing incidences of pulmonary diseases. Am J Med 1990 0.78
26 Salvage laryngectomy for unsuccessful larynx preservation therapy. Ann Otol Rhinol Laryngol 1995 0.77
27 Initial clinical trial of a high-affinity retinoic acid receptor ligand (LGD1550). Clin Cancer Res 2000 0.77
28 NCCN practice guidelines for head and neck cancer. National Comprehensive Cancer Network. Oncology (Williston Park) 1998 0.77
29 Base-of-tongue cancer treated with external beam irradiation plus brachytherapy: oncologic and functional outcome. Radiology 1992 0.76
30 Larynx preservation with combined chemotherapy and radiation therapy in advanced hypopharynx cancer. Otolaryngol Head Neck Surg 1994 0.76
31 Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC). Ann Oncol 2014 0.75
32 A new intensified therapeutic regimen for advanced head and neck squamous cell carcinomas: where does it fit among available treatment options? Cancer Invest 2001 0.75
33 BOMM: new solution or old problem? Cancer Invest 1991 0.75
34 Chemotherapy in locally advanced, squamous cell head and neck cancer: limitations, lessons learned, and evolving standards of care. Cancer Invest 1995 0.75
35 Chemotherapy as part of the initial treatment for nasopharyngeal cancer. Oncology (Williston Park) 1991 0.75
36 A prospective phase II trial of concomitant chemotherapy and radiotherapy with delayed accelerated fractionation in unresectable tumors of the head and neck. Head Neck 1998 0.75
37 High-dose edatrexate with oral leucovorin rescue: a phase I and clinical pharmacological study in adults with advanced cancer. Clin Cancer Res 1996 0.75
38 Chemotherapy and the management of locally advanced squamous cell carcinoma of the head and neck: role in larynx preservation. Important Adv Oncol 1991 0.75
39 Outcomes research studies. Oncology (Williston Park) 1996 0.75
40 Ifosfamide plus high-dose cisplatin in patients with non-small cell lung cancer previously treated with chemotherapy. Am J Clin Oncol 1995 0.75
41 Phase I and pharmacological study of two schedules of the antifolate edatrexate in combination with cisplatin. Clin Cancer Res 2001 0.75
42 Clinical economics of head and neck malignancies. Hematol Oncol Clin North Am 1999 0.75
43 Chemotherapy for recurrent disease and combined modality therapies for head and neck cancer. Curr Opin Oncol 1995 0.75